Search

Jonathan Silverberg, MD, PhD, MPHS, Gets Excited About the Upcoming RAD Conference
Jonathan Silverberg, MD, PHD, MPHS, talks about the exciting highlights of the Revolutionizing Atopic Dermatitis virtual conference on December 11.
Adam Friedman, MD featured in "6 Ways the Weather Messes With Your Skin" on HealthCentral
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article about the impacts of weather on skin on HealthCentral.com.
The Impact of Racial Disparities in the Diagnosis and Treatment of Atopic Dermatitis
Jonathan Silverberg, MD, PhD, MPH, discusses the importance of considering racial disparities in the diagnosis and treatment of atopic dermatitis on Medscape.com
Can You Get Psoriasis Behind the Knees?
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article about if the rash behind your knees is a psoriasis flare, plus what to do to clear it up on HealthCentral.com.
Minoxidil, drug that treats thinning hair, may be in short supply
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article about If patients can't fill prescriptions for the daily pill quickly, they may lose the hair they've regrown on NBC Health News.
Minoxidil may be in short supply. Here are 5 other hair loss treatments you can use instead.
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article for alternatives to Minoxidil for hair growth range from prescription medications like Finasteride to natural supplements like rosemary oil. For more information please click here.
Best of 2023- Modern Aesthetics
Pooja Sodha, MD, shares which fillers, lasers, and devices she got excited about in 2023 as well as the role of combination therapies. Dr. Sodha also tells what she hopes will be The Next Big Things in 2024. To learn more, please click here.
Monitoring Immunotherapy Toxicities in CSCC and BCC
Dr. Vishal Anil Patel, MD, Director of Cutaneous Oncology and Dermatologic Surgery, is featured in an article emphasizing the role of coordinated care between dermatologists and oncologists in monitoring and managing adverse events related to immunotherapy in CSCC and BCC. For more information,…
Plastic Surgery: Transgender/Gender Affirmation Surgery
Schedule A Consultation To learn more about any of these procedures, or to schedule a consultation, please contact us at 
A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Primary Outcome Measure: • To assess the safety and tolerability of tucatinib in combination with eribulin and trastuzumab in patients with unresectable or recurrent metastatic HER2+ breast cancer who have had prior treatment with trastuzumab, and trastuzumab deruxtecan. • Evaluate the relative…